{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:12:35Z","timestamp":1794431555787,"version":"4.9.1"},"reference-count":96,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T00:00:00Z","timestamp":1511136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>Preliminary data from the French cohort of the Safety and Appropriateness of Growth hormone treatments in Europe (<jats:styled-content style=\"fixed-case\">SAG<\/jats:styled-content>hE) study raised concerns regarding the safety of recombinant human <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content>, suggesting that <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content> may increase mortality and incidence of stroke in patients treated during childhood for <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content> deficiency or short stature. We evaluated published safety data, focusing on mortality, neoplasms, cerebrovascular events and diabetes across a number of large\u2010scale pharmaceutical company <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content> registries.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>A literature review was conducted using PubMed, <jats:styled-content style=\"fixed-case\">EMBASE<\/jats:styled-content> and Google Scholar to identify all relevant safety data from manufacturers' <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content> registries published between 1988 and April 2016. Results were hand\u2010sorted to exclude nonrelevant publications; bibliographic references from retrieved articles were evaluated for any additional references.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The published data do not support an increased risk of mortality in children or adults treated with <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content>. There was no evidence of an increased risk of stroke, new malignancy, leukaemia, nonleukaemic extracranial tumours or recurrence of intracranial malignancy in patients without risk factors. The risk of a second neoplasm is increased, particularly if patients have received radiation therapy for a central nervous system tumour. There may be an increased risk of type 2 diabetes in <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content>\u2010treated patients, but this appears to be confined to those with pre\u2010existing risk factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Patients with risk factors for malignancy or type 2 diabetes should be treated with caution and monitored during follow\u2010up, but current published data provide reassurance on the long\u2010term safety profile of <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content> in patients receiving <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content> treatment.<\/jats:p><\/jats:sec>","DOI":"10.1111\/cen.13502","type":"journal-article","created":{"date-parts":[[2017,10,21]],"date-time":"2017-10-21T14:52:37Z","timestamp":1508597557000},"page":"515-528","source":"Crossref","is-referenced-by-count":67,"title":["Long\u2010term safety of growth hormone\u2014A combined registry analysis"],"prefix":"10.1111","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4408-3413","authenticated-orcid":false,"given":"Kirstine","family":"Stochholm","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Diabetes, Endocrinology Aarhus University Hospital  Aarhus Denmark"},{"name":"Department of Pediatrics Center of Rare Diseases Aarhus University Hospital  Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wieland","family":"Kiess","sequence":"additional","affiliation":[{"name":"Department of Women and Child Health Hospital for Children and Adolescents University Hospitals University of Leipzig  Leipzig Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,11,20]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(97)70002-7"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1159\/000316130"},{"issue":"18","key":"e_1_2_8_4_1","first-page":"eS16","article-title":"Indications for recombinant human growth hormone and evaluation of available recombinant human growth hormone devices: implications for managed care organizations","volume":"17","author":"Dunn JD","year":"2011","journal-title":"Am J Manag Care"},{"key":"e_1_2_8_5_1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MED.0b013e32833b6bc7","article-title":"The diagnosis and treatment of growth hormone deficiency in adults","volume":"17","author":"Clemmons DR","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2011.09.004"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40124-013-0009-5"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1739"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/1687-9856-2013-S1-O15"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000737"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2882"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2294"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3271"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1159\/000435856"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-3023"},{"key":"e_1_2_8_16_1","unstructured":"ChildCJ ZimmermannAG QuigleyC RosenfeldR RobisonL BlumW.Mortality and GH treated (Tx) patients (pts) enrolled in the global genetics and neuroendocrinology of short stature international study (GeNeSIS). InEuropean Society of Endocrinology. Endocrine abstracts.2012."},{"issue":"2","key":"e_1_2_8_17_1","first-page":"278","article-title":"Update from the GHMonitorSM observational registry in children treated with recombinant human growth hormone (Saizen)","volume":"6","author":"Plotnick L","year":"2009","journal-title":"Pediatr Endocrinol Rev"},{"key":"e_1_2_8_18_1","unstructured":"PitukcheewanontP FranklinS LevyR et\u00a0al.The GHMonitorSM 6\u2010year results: efficacy of Saizen in treating growth hormone deficient children. InPediatric Academic Societies' Conference.2010."},{"issue":"1","key":"e_1_2_8_19_1","first-page":"83","article-title":"KIGS and KIMS as tools for evidence\u2010based medicine","volume":"51","author":"Ranke MB","year":"1999","journal-title":"Horm Res"},{"key":"e_1_2_8_20_1","unstructured":"Pfizer.KIGS.2015.https:\/\/kigs.pfizer.com\/. Accessed August 18 2016."},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0178"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/1687-9856-2013-9"},{"key":"e_1_2_8_23_1","unstructured":"PfaffleR KanumakalaS H\u00f6ybyeC et\u00a0al.Results up to January 2015 from PATRO Children a multi\u2010centre non\u2010interventional study of the long\u2010term safety and efficacy of Omnitrope\u00aein children requiring GH treatment. InEuropean Society of Endocrinology. Hormone Research in Paediatrics p.242.2015."},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/2042018813479644"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2684"},{"key":"e_1_2_8_26_1","unstructured":"ClinicalTrials.gov.A prospective observational study of effect of somatropin on growth hormone deficient adults (HypoCCS).2016.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01088399. Accessed May 4 2016."},{"key":"e_1_2_8_27_1","unstructured":"Pfizer.KIMS.2015.https:\/\/kims.pfizer.com\/. Accessed August 18 2016."},{"key":"e_1_2_8_28_1","doi-asserted-by":"crossref","unstructured":"Beck\u2010PeccozP H\u00f6ybyeC MurrayRD et\u00a0al.The PATRO adult study of Omnitrope\u00aefor the treatment of adult patients with GH deficiency: latest results. InEuropean Society of Endocrinology. Endocrine Abstracts p. EP665. 2015.","DOI":"10.1530\/endoabs.37.EP665"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S42602"},{"key":"e_1_2_8_30_1","unstructured":"ClinicalTrials.gov.An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin\u00ae(Human Growth Hormone) (ANSWER).2016.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01009905. Accessed May 4 2016."},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-1017"},{"key":"e_1_2_8_32_1","unstructured":"ClinicalTrials.gov.Observational prospective study on patients treated with Norditropin\u00ae.2016.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00960128?term=NCT00960128. Accessed May 4 2017."},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-015-0418-0"},{"issue":"2","key":"e_1_2_8_34_1","first-page":"1035","article-title":"Growth hormone safety update from the National Cooperative Growth Study","volume":"13","author":"Maneatis T","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-013-0529-6"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.11.4291"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-1028"},{"key":"e_1_2_8_38_1","first-page":"1","article-title":"Deaths: final data for 2007. National vital statistics reports","volume":"59","author":"Xu J","year":"2010","journal-title":"Natl Vital Stat Rep"},{"key":"e_1_2_8_39_1","unstructured":"JungH ZimmermannA MoD et\u00a0al.Mortality rates in childhood and adult onset GH deficient patients enrolled in the Global Hypopituitary Control and Complications Study (HypoCCS). InEuropean Society of Endocrinology. Endocrine Abstracts p.P1434.2012."},{"key":"e_1_2_8_40_1","first-page":"64","article-title":"Adult growth hormone deficiency \u2013 benefits, side effects, and risks of growth hormone replacement","volume":"4","author":"Reed ML","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"key":"e_1_2_8_41_1","first-page":"1021","article-title":"The cardiovascular system in growth hormone excess and growth hormone deficiency","volume":"35","author":"Lombardi G","year":"2012","journal-title":"J Endocrinol Invest"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0286"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-1123"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1159\/000444124"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0967"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2010.02.028"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-0287"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-0498"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.11.1207"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj411"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1159\/000101934"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1159\/000023133"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/08035250600577889"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-005-1202-9"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(89)90543-9"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0164"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)91968-X"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.1993.6.1.99"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(97)70008-8"},{"key":"e_1_2_8_60_1","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1210\/jcem.84.6.5716","article-title":"Recent status in the occurrence of leukemia in growth hormone\u2010treated patients in Japan. GH Treatment Study Committee of the Foundation for Growth Science, Japan","volume":"84","author":"Nishi Y","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(96)70003-3"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.5.1704"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.4.1416"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.151S055"},{"key":"e_1_2_8_65_1","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1542\/peds.104.S5.1045","article-title":"Melanocytic nevi in children treated with growth hormone","volume":"104","author":"Wyatt D","year":"1999","journal-title":"Pediatrics"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(98)70245-8"},{"issue":"2","key":"e_1_2_8_67_1","first-page":"689","article-title":"Characteristics of growth hormone therapy for pediatric patients with brain tumors in the National Cooperative Growth Study (NCGS) and from a survey of pediatric endocrinologists","volume":"15","author":"Meacham LR","year":"2002","journal-title":"J Pediatr Endocrinol Metab"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(96)70002-1"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1999.00695.x"},{"key":"e_1_2_8_70_1","first-page":"112","article-title":"Aspects of growth hormone (GH) replacement in elderly patients with GH deficiency: data from KIMS","volume":"60","author":"Monson JP","year":"2003","journal-title":"Horm Res"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0873"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x"},{"key":"e_1_2_8_73_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0806"},{"key":"e_1_2_8_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)04055-6"},{"key":"e_1_2_8_75_1","doi-asserted-by":"publisher","DOI":"10.1097\/00019616-200010041-00013"},{"key":"e_1_2_8_76_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1326"},{"key":"e_1_2_8_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03612.x"},{"key":"e_1_2_8_78_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0448"},{"key":"e_1_2_8_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1510"},{"key":"e_1_2_8_80_1","unstructured":"Monson J.P. Abs R. Bengtsson B.A. Feldt\u2010Rasmussen U. Goth M. Koltowska M. Mattsson A. Westberg B. & Wilton P.Safety and mortality during growth hormone (GH) replacement therapy in 4457 adult GH\u2010deficient patients \u2013 a KIMS database analysis. InEuropean Society of Endocrinology. Endocrine Abstracts p.P68.2001."},{"key":"e_1_2_8_81_1","doi-asserted-by":"publisher","DOI":"10.4158\/EP.12.6.682"},{"key":"e_1_2_8_82_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0449"},{"key":"e_1_2_8_83_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1013"},{"key":"e_1_2_8_84_1","doi-asserted-by":"crossref","unstructured":"WeberM PedersenBT PournaraE ChristiansenJS H\u00f6ybyeC.GH therapy has a beneficial effect on HbA1c levels in adult patients with GH deficiency: a report from the NordiNet\u00aeInternational Outcome Study. InEuropean Society of Endocrinology. Endocrine Abstracts Dublin p.S9.2015.","DOI":"10.1530\/endoabs.37.EP667"},{"key":"e_1_2_8_85_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1995"},{"key":"e_1_2_8_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13131"},{"key":"e_1_2_8_87_1","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12848"},{"key":"e_1_2_8_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2015.06.006"},{"key":"e_1_2_8_89_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-015-0840-2"},{"key":"e_1_2_8_90_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-016-2306-7"},{"key":"e_1_2_8_91_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-1156-6"},{"key":"e_1_2_8_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2014.02.001"},{"key":"e_1_2_8_93_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3697"},{"key":"e_1_2_8_94_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2364"},{"key":"e_1_2_8_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(96)70001-X"},{"key":"e_1_2_8_96_1","unstructured":"ClinicalTrials.gov.Observational Study of Somatropin Treatment in Children (GeNeSIS).2015.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01088412. Accessed May 4 2016."},{"key":"e_1_2_8_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2005.12.009"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcen.13502","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cen.13502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T07:22:38Z","timestamp":1695540158000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cen.13502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,20]]},"references-count":96,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["10.1111\/cen.13502"],"URL":"https:\/\/doi.org\/10.1111\/cen.13502","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,20]]}}}